David Sinclair sold his original resveratrol research to pharmaceutical giant GSK for 720 million dollars; after GSK spent millions more and determined it was a dead end, they shuttered their resveratrol divisions, yet the hype continues despite multiple mouse experiments showing no benefits and multiple human studies showing no benefits.
factualpending
Evidence Quote
“David Sinclair sold his original Resveratrol research to the the pharmaceutical giant GSK for an eye-watering 720 million dollars after GSK spent Millions more and realizing that this was a dead end they shuttered their Resveratrol into two in divisions unfortunately the Resveratrol hype continues to this day despite multiple mice experiments showing no benefits from Resveratrol whatsoever despite clear evidence of absorption of Resveratrol into the bloodstream there's also no benefits from multiple human studies”
Created: 8/10/2026, 9:22:16 PM
Your notes
Loading notes...